Clinical progression at initiation of a life-extending therapy (LET) in metastatic castration-resistant prostate cancer (mCRPC) is associated with a poor prognosis, whatever the tr... von Delanoy, Nicolas, Hardy-Bessard, Anne-Claire, Le Moulec, Sylvestre, Basso, Umberto, Birtle, Alison Jane, Thomson, Alastair H, Krainer, Michael, De Giorgi, Ugo, Hasbini, Ali, Daugaard, Kirsten Gedske, Bahl, Amit, Chowdhury, Simon, Caffo, Orazio, Beuzeboc, Philippe, Spaeth, Dominique, Eymard, Jean-Christophe, Flechon, Aude, Thiery-Vuillemin, Antoine, Efstathiou, Eleni, Oudard, Stephane

Volltext

Association of clinical progression at initiation of a life-extending therapy (LET) in metastatic castration-resistant prostate cancer (mCRPC) with poor prognosis: Results of the C... von Oudard, Stephane, Hardy-Bessard, Anne-Claire, Le Moulec, Sylvestre, Basso, Umberto, Birtle, Alison Jane, Thomson, Alastair H, Guillot, Aline, De Giorgi, Ugo, Hasbini, Ali, Gedske Daugaard, Kirsten, Chowdhury, Simon, Caffo, Orazio, Beuzeboc, Philippe, Spaeth, Dominique, Flechon, Aude, Alexandre, Jerome, Morales Barrera, Rafael, Thiery-Vuillemin, Antoine, Fizazi, Karim, Efstathiou, Eleni

Volltext

Survival and toxicity in patients with disseminated germ-cell cancer above 40 years of age von Thomsen, Frederik Birkebæk, Bandak, Mikkel, Thomsen, Maria Ferløv, Lauritsen, Jakob, Christensen, Ib Jarle, Gedske Daugaard, Kirsten

Volltext